Top 30 Stocks Under $60
Discover investment opportunities in Top 30 Stocks Under $60 using our Smart AI Filter.
AI is processing your request...
AI is analyzing your request
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 30 Stocks Under $60 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 30 Stocks Under $60 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 30 Stocks Under $60 using our Smart AI Filter.
10 stocks found for "Top 30 Stocks Under $60"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
---|---|---|---|---|---|---|
2.23 Risk measure | ±99.6% Price volatility | 441.5 Valuation | 0.00% Annual yield | |||
1.91 Risk measure | ±77.6% Price volatility | -1.5 Valuation | 3.19% Annual yield | |||
0.95 Risk measure | ±48.1% Price volatility | 71.5 Valuation | 0.00% Annual yield | |||
0.85 Risk measure | ±64.0% Price volatility | -5.8 Valuation | 0.00% Annual yield | |||
1.54 Risk measure | ±98.7% Price volatility | 63.0 Valuation | 86.34% Annual yield | |||
0.61 Risk measure | ±38.9% Price volatility | 6.7 Valuation | 5.08% Annual yield | |||
1.36 Risk measure | ±73.8% Price volatility | 285.9 Valuation | 0.00% Annual yield | |||
1.28 Risk measure | ±78.3% Price volatility | -2.4 Valuation | 0.00% Annual yield | |||
0.32 Risk measure | ±24.8% Price volatility | 8.7 Valuation | 6.75% Annual yield | |||
1.16 Risk measure | ±85.2% Price volatility | -18.7 Valuation | 0.00% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: What is the growth potential of Palantir Technologies (PLTR) for investors?
A: Palantir Technologies operates in the data analytics sector. Some investors consider its government contracts and expanding commercial client base as avenues for growth. However, as the company is still expanding, its profitability and long-term growth trajectory should be monitored.
Q: How does Pfizer (PFE) maintain a competitive advantage in the pharmaceutical sector?
A: Pfizer is a leading pharmaceutical company benefited by its broad drug portfolio, R&D capabilities, and market presence. It often reinvests in new drug pipelines and strategic partnerships to sustain competitive advantage in a highly competitive industry.
Q: Is Marathon Digital Holdings (MARA) a stable investment in the cryptocurrency mining industry?
A: Marathon Digital Holdings focuses on cryptocurrency mining, a volatile industry prone to fluctuations based on digital coin prices and regulatory changes. It requires careful consideration of Bitcoin price trends and mining efficiency.
Q: Does Ford Motor Company (F) offer dividend income for investors?
A: Ford Motor Company periodically pays dividends, making it potentially attractive for income-focused investors. However, dividend resumption and amounts can be influenced by its financial performance and industry conditions.
Q: What are the risks of investing in Viking Therapeutics (VKTX) in the biotech sector?
A: Viking Therapeutics operates in biotech, which is inherently risky due to reliance on drug development successes and regulatory approvals. Investors should be cautious about potential delays or failures in clinical trials.
Q: How might DraftKings (DKNG) perform in economic downturns?
A: DraftKings, in the online sports betting industry, may face challenges during economic downturns as discretionary spending decreases. However, its scalable business model could help mitigate some adverse effects.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Read moreCommerce Secretary Howard Lutnick said Tuesday that the Trump administration is considering buying ownership stakes in major defense contractors, similar to its recent controversial move to acquire part of chipmaker Intel Corp. INTC.
Read more